This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

E. M. BUTT, M.D.; A. M. HOFFMAN, M.D.; S. N. SOLL, M.D.

Arch Intern Med. 1939;64(1):26-42.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The reproduction of the classic clinical picture of malignant neutropenia, or agranulocytic angina, in experimental animals has never been accomplished successfully. The situation in regard to aminopyrine as the most common etiologic agent in agranulocytic angina in man is much the same today as that in regard to cinchophen as the cause of acute necrosis of the liver. Cinchophen is generally accepted as the toxic agent in production of acute yellow atrophy in certain susceptible persons. In the experimental animal, however, cinchophen has never produced necrosis of the liver in any degree sufficient to simulate the condition in man. Aminopyrine today is accepted by many as the responsible agent in agranulocytic angina. True, it is apparently harmless to the vast majority of patients. Rawls¹ estimated on clinical grounds that only 1 to 2 per cent of patients are susceptible to demonstrable changes in the peripheral blood; this view is . . . [Full Text PDF of this Article]

Author Affiliations
LOS ANGELES

From the Departments of Pathology and Medicine, University of Southern California School of Medicine, and the Santa Fe Coast Lines Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?